Keenova Therapeutics plc Total Liabilities
Keenova Therapeutics plc had Total Liabilities of $3.46 billion as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-11
- 2026-06-30: Liabilities $3.46B.
- 2026-03-31: Liabilities $3.52B.
- 2025-12-31: Liabilities $3.56B.
- 2025-09-26: Liabilities $5.32B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $3.46B 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $3.52B 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $3.56B 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $5.32B 10-Q · filed 2025-11-10 | |
| 2025-06-27 | $1.64B 10-Q · filed 2025-08-06 | |
| 2025-03-28 | $1.68B 10-Q · filed 2025-05-12 | |
| 2024-12-27 | $1.66B 10-K · filed 2026-04-15 | |
| 2024-09-27 | $2.61B 10-Q · filed 2024-11-05 | |
| 2024-06-28 | $2.53B 10-Q · filed 2024-08-06 | |
| 2024-03-29 | $2.54B 10-Q · filed 2024-05-09 | |
| 2023-12-29 | $2.57B 10-K · filed 2025-03-13 | |
| 2023-09-29 | $5.89B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $4.48B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.41B 10-Q · filed 2023-05-09 | |
| 2022-12-30 | $4.40B 10-K · filed 2024-03-26 | |
| 2022-09-30 | $4.41B 10-Q · filed 2022-11-08 | |
| 2022-07-01 | $4.35B 10-Q · filed 2022-08-11 | |
| 2022-04-01 | $8.51B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $8.60B 10-K · filed 2023-03-03 | |
| 2021-09-24 | $8.64B 10-Q · filed 2021-11-02 | |
| 2021-06-25 | $8.56B 10-Q · filed 2021-08-03 | |
| 2021-03-26 | $8.56B 10-Q · filed 2021-05-04 | |
| 2020-12-25 | $8.70B 10-K · filed 2022-03-15 | |
| 2020-09-25 | $8.54B 10-Q · filed 2020-11-03 | |
| 2020-06-26 | $8.72B 10-Q · filed 2020-08-04 | |
| 2020-03-27 | $8.28B 10-Q · filed 2020-05-06 | |
| 2019-12-27 | $8.40B 10-K · filed 2021-03-10 | |
| 2019-09-27 | $7.28B 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $7.15B 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $7.50B 10-Q · filed 2019-05-07 | |
| 2018-12-28 | $7.99B 10-K · filed 2020-02-26 | |
| 2018-09-28 | $8.30B 10-Q · filed 2018-11-06 | |
| 2018-06-29 | $8.58B 10-Q · filed 2018-08-07 | |
| 2018-03-30 | $9.06B 10-Q · filed 2018-05-08 | |
| 2017-12-29 | $8.76B 10-K · filed 2019-02-26 | |
| 2017-09-29 | $9.50B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $9.53B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $9.66B 10-Q · filed 2017-05-08 | |
| 2016-12-30 | $10.22B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $10.23B 10-QT · filed 2017-02-07 | |
| 2016-06-24 | $10.62B 10-Q · filed 2016-08-02 | |
| 2016-03-25 | $10.81B 10-Q · filed 2016-05-03 | |
| 2015-12-25 | $10.85B 10-Q · filed 2016-02-02 | |
| 2015-09-25 | $11.09B 10-K · filed 2016-11-29 | |
| 2015-06-26 | $9.58B 10-Q · filed 2015-08-04 | |
| 2015-03-27 | $7.63B 10-Q · filed 2015-05-05 | |
| 2014-12-26 | $7.70B 10-Q · filed 2015-02-03 | |
| 2014-09-26 | $7.83B 10-K · filed 2015-11-24 | $7.91B 10-K · filed 2014-11-25 |
| 2014-06-27 | $4.09B 10-Q · filed 2014-08-07 | |
| 2014-03-28 | $4.12B 10-Q · filed 2014-05-08 | |
| 2013-12-27 | $2.26B 10-Q · filed 2014-02-07 | |
| 2013-09-27 | $2.30B 8-K · filed 2015-04-03 | |
| 2013-06-28 | $2.15B 10-Q · filed 2013-08-12 | |
| 2012-09-28 | $1.01B 10-K · filed 2013-12-13 | $982.70M 10-Q · filed 2013-08-12 |